These pathways can be initiated by complications associated with CKD, such as metabolic acidosis, defective insulin and IGF-1 signaling, inflammation, increased angiotensin II levels, abnormal appetite regulation, and impaired microRNA responses [175]. The gene discussed is IGF1; the disease is chronic kidney disease.